Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association

RM Carey, DA Calhoun, GL Bakris, RD Brook… - …, 2018 - Am Heart Assoc
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in …

PK Whelton, RM Carey, WS Aronow, DE Casey… - Journal of the American …, 2018 - jacc.org
As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018

American Diabetes Association - Diabetes care, 2018 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …

Cardiorenal syndrome revisited

F Zannad, P Rossignol - Circulation, 2018 - Am Heart Assoc
Cardiorenal syndromes have been categorized into 5 clinical subtypes based on which
organ is perceived to be the primary precipitant of the vicious and interrelated cycle of …

[HTML][HTML] Arterial hypertension: diagnosis and treatment

J Jordan, C Kurschat, H Reuter - Deutsches Ärzteblatt International, 2018 - ncbi.nlm.nih.gov
Background Essential arterial hypertension is one of the main treatable cardiovascular risk
factors. In Germany, approximately 13% of women and 18% of men have uncontrolled high …

The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment

A Vaidya, P Mulatero, R Baudrand… - Endocrine …, 2018 - academic.oup.com
Primary aldosteronism is characterized by aldosterone secretion that is independent of renin
and angiotensin II and sodium status. The deleterious effects of primary aldosteronism are …

[HTML][HTML] Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 …

B Williams, TM MacDonald, SV Morant… - The lancet Diabetes & …, 2018 - thelancet.com
Background In the PATHWAY-2 study of resistant hypertension, spironolactone reduced
blood pressure substantially more than conventional antihypertensive drugs. We did three …

Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension: the ReHOT randomized study (Resistant Hypertension Optimal Treatment)

EM Krieger, LF Drager, DMA Giorgi, AC Pereira… - …, 2018 - Am Heart Assoc
The aim of this study is to compare spironolactone versus clonidine as the fourth drug in
patients with resistant hypertension in a multicenter, randomized trial. Medical therapy …

10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018

American Diabetes Association - Diabetes care, 2018 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …